Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer-Reference-Cited by-同舟云学术

Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer

Published:2015-02 Issue:1 Volume:150 Page:71-80
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Wong-Brown Michelle W.,Meldrum Cliff J.,Carpenter Jane E.,Clarke Christine L.,Narod Steven A.,Jakubowska Anna,Rudnicka Helena,Lubinski Jan,Scott Rodney J.

Funder

National Breast Cancer Foundation

Cancer Institute New South Wales

Hunter Translational Cancer Research Alliance

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3293-7.pdf

Reference22 articles.

1. Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL (2003) Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 95(6):448–457

2. Nathanson KL, Wooster R, Weber BL (2001) Breast cancer genetics: what we know and what we need. Nat Med 7(5):552–556

3. Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, Lanchbury JS, Stemke-Hale K, Hennessy BT, Arun BK et al (2011) Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res 17(5):1082–1089

4. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, Easton DF (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310–2318

5. Turner N, Tutt A, Ashworth A (2004) Hallmarks of ‘BRCAness’ in sporadic cancers. Nat Rev Cancer 4(10):814–819

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients;Genes;2024-07-18

2. A high-throughput approach to identify BRCA1-downregulating compounds to enhance PARP inhibitor sensitivity;iScience;2024-07

3. Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations;npj Precision Oncology;2024-04-30

4. APIR: Aggregating Universal Proteomics Database Search Algorithms for Peptide Identification with FDR Control;Genomics, Proteomics & Bioinformatics;2024-04

5. Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline;Journal of Clinical Oncology;2024-02-10